NCT05631886
- Conditions
- Disease Attributes, EphA2 Overexpression, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying TP53 R175H. Study availability and eligibility vary by location and protocol.
NCT05631886